BioSpace News Archive

Reviva Pharmaceuticals Holdings, Inc. announced that the Company will be added to the Russell Microcap® Index, effective after the United States market opens on Monday, June 26, 2023, following the conclusion of the 2023 Russell indexes annual reconstitution.

Rockwell Medical, Inc., a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company was added to the Russell Microcap® Index.

RetinalGeniX™ Technologies, Inc., previewed the completion of an Institutional Review Board for research on its DNA/GPS program.

Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism pioneering therapies for rare diseases, announced that the Phase 2 portion of the global RISE UP study of mitapivat in sickle cell disease met its primary endpoint of hemoglobin response for patients in both the 50 mg and 100 mg twice daily mitapivat arms.

Pharvaris (Nasdaq: PHVS) today announced the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on the Investigational New Drug (IND) application for deucrictibant for the on-demand treatment of HAE following review of data from a preplanned interim analysis of the ongoing 26-week nonclinical study.

Larkspur Biosciences revealed today that one of their lead programs is a first-in-class B cell checkpoint, TIM-1.

Tonix Pharmaceuticals Holding Corp. today announced that they have entered into an agreement to acquire two currently-marketed products from Upsher-Smith Laboratories, LLC (Upsher-Smith): Zembrace® SymTouch® (sumatriptan injection) 3 mg and Tosymra® (sumatriptan nasal spray) 10 mg. Zembrace SymTouch and Tosymra are both indicated for the treatment of acute migraine with or without aura in adults.

Marker Therapeutics, Inc. today reports non-clinical data on its lead multi-tumor-associated antigen (multiTAA)-specific T cell product candidate, MT-401, which showed increased anti-tumor activity against an acute myeloid leukemia (AML) cell line after treatment with hypomethylating agents (HMA).

Sotera Health Company, a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, announced that Jon Lyons has joined the Company, effective , as Senior Vice President and Chief Financial Officer.

Medtronic announced today that its Board of Directors appointed Greg Lewis , Senior Vice President and Chief Financial Officer at Honeywell, to the Board.